1181 related articles for article (PubMed ID: 19833310)
1. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
[TBL] [Abstract][Full Text] [Related]
2. Connectivity of radiotracers to vasodilators is thallium the missing link?
Dilsizian V
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1209-12. PubMed ID: 19833311
[No Abstract] [Full Text] [Related]
3. Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs.
Leon AR; Eisner RL; Martin SE; Schmarkey LS; Aaron AM; Boyers AS; Burnham KM; Oh DJ; Patterson RE
J Am Coll Cardiol; 1992 Dec; 20(7):1612-25. PubMed ID: 1452936
[TBL] [Abstract][Full Text] [Related]
4. Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses.
Hatada K; Ruiz M; Riou LM; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Cardiol; 2006 Nov; 13(6):779-90. PubMed ID: 17174809
[TBL] [Abstract][Full Text] [Related]
5. Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion. Comparison with adenosine stress.
Calnon DA; Ruiz M; Vanzetto G; Watson DD; Beller GA; Glover DK
Circulation; 1999 Oct; 100(15):1653-9. PubMed ID: 10517738
[TBL] [Abstract][Full Text] [Related]
6. Use of regadenoson for measurement of fractional flow reserve.
Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM
Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847
[TBL] [Abstract][Full Text] [Related]
7. Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A(2A) receptor agonist.
He ZX; Cwajg E; Hwang W; Hartley CJ; Funk E; Michael LH; Verani MS
Circulation; 2000 Jul; 102(4):438-44. PubMed ID: 10908217
[TBL] [Abstract][Full Text] [Related]
8. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.
Lieu HD; Shryock JC; von Mering GO; Gordi T; Blackburn B; Olmsted AW; Belardinelli L; Kerensky RA
J Nucl Cardiol; 2007 Jul; 14(4):514-20. PubMed ID: 17679059
[TBL] [Abstract][Full Text] [Related]
9. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.
Hendel RC; Bateman TM; Cerqueira MD; Iskandrian AE; Leppo JA; Blackburn B; Mahmarian JJ
J Am Coll Cardiol; 2005 Dec; 46(11):2069-75. PubMed ID: 16325044
[TBL] [Abstract][Full Text] [Related]
10. Arbutamine stress perfusion imaging in dogs with critical coronary artery stenoses: (99m)Tc-sestamibi versus (201)Tl.
Ruiz M; Takehana K; Petruzella FD; Watson DD; Beller GA; Glover DK
J Nucl Med; 2002 May; 43(5):664-70. PubMed ID: 11994532
[TBL] [Abstract][Full Text] [Related]
11. Regadenoson in the detection of coronary artery disease.
Buhr C; Gössl M; Erbel R; Eggebrecht H
Vasc Health Risk Manag; 2008; 4(2):337-40. PubMed ID: 18561509
[TBL] [Abstract][Full Text] [Related]
12. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
[TBL] [Abstract][Full Text] [Related]
13. Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging.
Berman DS; Kang X; Tamarappoo B; Wolak A; Hayes SW; Nakazato R; Thomson LE; Kite F; Cohen I; Slomka PJ; Einstein AJ; Friedman JD
JACC Cardiovasc Imaging; 2009 Mar; 2(3):273-82. PubMed ID: 19356571
[TBL] [Abstract][Full Text] [Related]
14. Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist.
Le DE; Bragadeesh T; Zhao Y; Wang YG; Zha D; Kaul S
Eur Heart J Cardiovasc Imaging; 2012 Apr; 13(4):298-308. PubMed ID: 22067143
[TBL] [Abstract][Full Text] [Related]
15. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
[TBL] [Abstract][Full Text] [Related]
16. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity.
Glover DK; Ruiz M; Edwards NC; Cunningham M; Simanis JP; Smith WH; Watson DD; Beller GA
Circulation; 1995 Feb; 91(3):813-20. PubMed ID: 7828310
[TBL] [Abstract][Full Text] [Related]
17. Myocardial uptake of 7'-(Z)-[(123)I]iodorotenone during vasodilator stress in dogs with critical coronary stenoses.
Broisat A; Ruiz M; Goodman NC; Hanrahan SM; Reutter BW; Brennan KM; Janabi M; Schaefer S; Watson DD; Beller GA; VanBrocklin HF; Glover DK
Circ Cardiovasc Imaging; 2011 Nov; 4(6):685-92. PubMed ID: 21917783
[TBL] [Abstract][Full Text] [Related]
18. Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium.
Melon PG; Beanlands RS; DeGrado TR; Nguyen N; Petry NA; Schwaiger M
J Am Coll Cardiol; 1992 Nov; 20(5):1277-83. PubMed ID: 1401632
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of reversible (99m)Tc-sestamibi perfusion defects during pharmacologically induced vasodilatation.
Wei K; Le E; Bin JP; Coggins M; Jayawera AR; Kaul S
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1896-904. PubMed ID: 11247807
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of detection of myocardial viability and residual infarct vessel stenoses with rest Tl-201 and adenosine Tc-99m sestamibi imaging after coronary reperfusion in dogs with experimental acute myocardial infarction.
Takehana K; Beller GA; Ruiz M; Petruzella FD; Watson DD; Glover DK
J Nucl Cardiol; 2003; 10(4):375-84. PubMed ID: 12900742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
